의약품 도매 및 유통 시장(2026-2030년)

The global pharmaceuticals wholesale and distribution market is forecasted to grow by USD 1097.1 bn during 2025-2030, accelerating at a CAGR of 9.7% during the forecast period. The report on the global pharmaceuticals wholesale and distribution market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic diseases, aging global population, growth in specialty and biologic drugs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global pharmaceuticals wholesale and distribution market is segmented as below:

By Type

• Branded drugs
• Generic drugs

By End-User

• Retail pharmacies
• Hospital pharmacies
• Others

By Service

• Warehousing and storage
• Cold chain logistics
• Direct-to-pharmacy (DTP) distribution
• Specialty drug distribution

Geography

• North America
  • US
  • Canada
  • Mexico
• Asia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • The Netherlands
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the adoption of digital technologies and artificial intelligence as one of the prime reasons driving the global pharmaceuticals wholesale and distribution market growth during the next few years. Also, rising focus on supply chain resilience and diversification and emergence of drones and advanced logistics innovations will lead to sizable demand in the market.

The report on the global pharmaceuticals wholesale and distribution market covers the following areas:

• Global pharmaceuticals wholesale and distribution market sizing
• Global pharmaceuticals wholesale and distribution market forecast
• Global pharmaceuticals wholesale and distribution market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global pharmaceuticals wholesale and distribution market vendors that include Alfresa Holdings Corp., Alliance Healthcare, Cardinal Health Inc., Cencora Inc., Dakota Drug Inc., FFF Enterprises Inc., Hauser Pharmaceutical Inc., J M Smith Corp., McKesson Corp., Medipal Holdings Corp., Medline Inc., Morris and Dickson Co. LLC, Mutual Drug, Owens and Minor Inc., PHOENIX Pharma SE, Shanghai Fosun Pharmaceutical, Suzuken Co. Ltd., The Cigna Group. Also, the global pharmaceuticals wholesale and distribution market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Service
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Pharmaceuticals Wholesale And Distribution Market 2020 - 2024
  • Historic Market Size - Data Table on Global Pharmaceuticals Wholesale And Distribution Market 2020 - 2024 ($ billion)
• 5.2 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ billion)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ billion)
• 5.4 Service segment analysis 2020 - 2024
  • Historic Market Size - Service Segment 2020 - 2024 ($ billion)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ billion)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ billion)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Pharmaceuticals Wholesale and Distribution Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Type

• 8.1 Market segments
• 8.2 Comparison by Type
• 8.3 Branded drugs - Market size and forecast 2025-2030
• 8.4 Generic drugs - Market size and forecast 2025-2030
• 8.5 Market opportunity by Type
  • Market opportunity by Type ($ billion)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Retail pharmacies - Market size and forecast 2025-2030
• 9.4 Hospital pharmacies - Market size and forecast 2025-2030
• 9.5 Others - Market size and forecast 2025-2030
• 9.6 Market opportunity by End-user
  • Market opportunity by End-user ($ billion)

10 Market Segmentation by Service

• 10.1 Market segments
• 10.2 Comparison by Service
• 10.3 Warehousing and storage - Market size and forecast 2025-2030
• 10.4 Cold chain logistics - Market size and forecast 2025-2030
• 10.5 Direct-to-pharmacy (DTP) distribution - Market size and forecast 2025-2030
• 10.6 Specialty drug distribution - Market size and forecast 2025-2030
• 10.7 Market opportunity by Service
  • Market opportunity by Service ($ billion)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Asia - Market size and forecast 2025-2030
  • 12.4.1 China - Market size and forecast 2025-2030
  • 12.4.2 Japan - Market size and forecast 2025-2030
  • 12.4.3 India - Market size and forecast 2025-2030
  • 12.4.4 South Korea - Market size and forecast 2025-2030
  • 12.4.5 Indonesia - Market size and forecast 2025-2030
  • 12.4.6 Thailand - Market size and forecast 2025-2030
• 12.5 Europe - Market size and forecast 2025-2030
  • 12.5.1 Germany - Market size and forecast 2025-2030
  • 12.5.2 France - Market size and forecast 2025-2030
  • 12.5.3 UK - Market size and forecast 2025-2030
  • 12.5.4 Italy - Market size and forecast 2025-2030
  • 12.5.5 Spain - Market size and forecast 2025-2030
  • 12.5.6 The Netherlands - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Turkey - Market size and forecast 2025-2030
  • 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.4 South Africa - Market size and forecast 2025-2030
  • 12.6.5 UAE - Market size and forecast 2025-2030
  • 12.6.6 Argentina - Market size and forecast 2025-2030
  • 12.6.7 Colombia - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ billion)
  • Data Tables on Market opportunity by geography ($ billion)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising prevalence of chronic diseases
  • Aging global population
  • Growth in specialty and biologic drugs
• 13.2 Market challenges
  • Persistent drug shortages
  • Increasing regulatory complexity in pharma industry
  • Geopolitical and trade disruptions
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Adoption of digital technologies and artificial intelligence
  • Rising focus on supply chain resilience and diversification
  • Emergence of drones and advanced logistics innovations

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Alfresa Holdings Corp.
  • Alfresa Holdings Corp. - Overview
  • Alfresa Holdings Corp. - Business segments
  • Alfresa Holdings Corp. - Key offerings
  • Alfresa Holdings Corp. - Segment focus
  • SWOT
• 15.5 Alliance Healthcare
  • Alliance Healthcare - Overview
  • Alliance Healthcare - Product / Service
  • Alliance Healthcare - Key offerings
  • SWOT
• 15.6 Cardinal Health Inc.
  • Cardinal Health Inc. - Overview
  • Cardinal Health Inc. - Business segments
  • Cardinal Health Inc. - Key news
  • Cardinal Health Inc. - Key offerings
  • Cardinal Health Inc. - Segment focus
  • SWOT
• 15.7 Cencora Inc.
  • Cencora Inc. - Overview
  • Cencora Inc. - Business segments
  • Cencora Inc. - Key offerings
  • Cencora Inc. - Segment focus
  • SWOT
• 15.8 FFF Enterprises Inc.
  • FFF Enterprises Inc. - Overview
  • FFF Enterprises Inc. - Product / Service
  • FFF Enterprises Inc. - Key offerings
  • SWOT
• 15.9 J M Smith Corp.
  • J M Smith Corp. - Overview
  • J M Smith Corp. - Product / Service
  • J M Smith Corp. - Key offerings
  • SWOT
• 15.10 McKesson Corp.
  • McKesson Corp. - Overview
  • McKesson Corp. - Business segments
  • McKesson Corp. - Key news
  • McKesson Corp. - Key offerings
  • McKesson Corp. - Segment focus
  • SWOT
• 15.11 Medipal Holdings Corp.
  • Medipal Holdings Corp. - Overview
  • Medipal Holdings Corp. - Business segments
  • Medipal Holdings Corp. - Key offerings
  • Medipal Holdings Corp. - Segment focus
  • SWOT
• 15.12 Medline Inc.
  • Medline Inc. - Overview
  • Medline Inc. - Product / Service
  • Medline Inc. - Key offerings
  • SWOT
• 15.13 Morris and Dickson Co. LLC
  • Morris and Dickson Co. LLC - Overview
  • Morris and Dickson Co. LLC - Product / Service
  • Morris and Dickson Co. LLC - Key offerings
  • SWOT
• 15.14 Owens and Minor Inc.
  • Owens and Minor Inc. - Overview
  • Owens and Minor Inc. - Business segments
  • Owens and Minor Inc. - Key news
  • Owens and Minor Inc. - Key offerings
  • Owens and Minor Inc. - Segment focus
  • SWOT
• 15.15 PHOENIX Pharma SE
  • PHOENIX Pharma SE - Overview
  • PHOENIX Pharma SE - Product / Service
  • PHOENIX Pharma SE - Key offerings
  • SWOT
• 15.16 Shanghai Fosun Pharmaceutical
  • Shanghai Fosun Pharmaceutical - Overview
  • Shanghai Fosun Pharmaceutical - Business segments
  • Shanghai Fosun Pharmaceutical - Key offerings
  • Shanghai Fosun Pharmaceutical - Segment focus
  • SWOT
• 15.17 Suzuken Co. Ltd.
  • Suzuken Co. Ltd. - Overview
  • Suzuken Co. Ltd. - Business segments
  • Suzuken Co. Ltd. - Key offerings
  • Suzuken Co. Ltd. - Segment focus
  • SWOT
• 15.18 The Cigna Group
  • The Cigna Group - Overview
  • The Cigna Group - Business segments
  • The Cigna Group - Key offerings
  • The Cigna Group - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations